Company
alida
Turnkey profiling and in-lab kits for m6A, inosine, and pseudouridine—one platform, one workflow.
Also known as ALIDA BIOSCIENCES INC., AlidaBio
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- Researchers
- Legal name
- ALIDA BIOSCIENCES INC.
Claim, correct or request removal
Record updated 28 September 2026
About
Alida Biosciences’ technologies are designed to unleash the transformative potential of epitranscriptomics in basic research and applications in RNA-centered diagnostics and therapeutics. Proximity barcoding translates sequencing-silent RNA modifications into NGS-readable barcodes.
Funding snapshot
- Total raised
- $12MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $7.5M2024-06-07
Funding rounds
- Round, 2024
- $7.5M2024-06-07, SEC form D sold, 3 investors
- Round, 2022
- $4M2022-05-11, SEC form D sold, 2 investors
- Round, 2021
- $510K2021-06-21, SEC form D sold, 4 investors
Products
- Other
- EpiPlex
- Web
- EpiScout Analysis Software
Loading relationship preview